Bottom line
How much do RYHIX and PINK overlap?
45% of their top holdings overlap by weight. 13 securities appear in both funds' top 25, making up 22.5% of RYHIX's assets and 46.9% of PINK's. They share a meaningful core but differ in the rest of the portfolio.
RYHIX holds far more positions (135 vs 54), so it is broader beyond the top names.
Updated Nov 22, 2026
Overlap at a glance
Holdings RYHIX and PINK have in common
| Holding | % of RYHIX | % of PINK | Overlap |
|---|---|---|---|
| Eli Lilly & Company LLY | 3.63% | 5.91% | 3.63% |
| Johnson & Johnson JNJ | 2.88% | 5.45% | 2.88% |
| Abbvie Inc ABBV | 2.52% | 4.52% | 2.52% |
| Unitedhealth Group Inc UNH | 2.22% | 5.76% | 2.22% |
| Thermo Fisher Scientific Inc TMO | 1.61% | 3.23% | 1.61% |
| Amgen Inc AMGN | 1.56% | 2.12% | 1.56% |
| Gilead Sciences Inc GILD | 1.39% | 2.87% | 1.39% |
| Vertex Pharmaceuticals Inc VRTX | 1.34% | 1.45% | 1.34% |
| Cvs Health Corp CVS | 1.31% | 2.01% | 1.31% |
| Danaher Corp DHR | 1.30% | 2.28% | 1.30% |
| Elevance Health Inc ELV | 1.02% | 2.73% | 1.02% |
| Cardinal Health Inc CAH | 0.86% | 1.78% | 0.86% |
| Novo Nordisk A/s NVO | 0.83% | 6.75% | 0.83% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in RYHIX
- Merck & Company Inc — 2.04%
- Abbott Laboratories — 1.42%
- Intuitive Surgical Inc — 1.31%
- Pfizer Inc — 1.25%
- Bristol-myers Squibb Company — 1.22%
- Stryker Corp — 1.21%
- Mckesson Corp — 1.05%
- Cigna Group (the) — 0.94%
- Regeneron Pharmaceuticals Inc — 0.90%
- Hca Healthcare Inc — 0.87%
- Boston Scientific Corp — 0.86%
- Edwards Lifesciences Corp — 0.84%
Only in PINK
- Purecycle Technologies Inc — 6.89%
- United Therapeutics Corp — 6.86%
- Warby Parker Inc — 5.46%
- Jazz Pharmaceuticals Plc — 4.61%
- Biohaven Ltd — 4.32%
- Benitec Biopharma Inc — 3.75%
- Align Technology Inc — 3.14%
- 10x Genomics Inc — 3.13%
- Quest Diagnostics Inc — 2.94%
- Astrazeneca Plc — 1.81%
- Establishment Labs Holdings Inc — 1.45%
- Eyepoint Inc — 1.44%
Asset mix
| Asset type | RYHIX | PINK |
|---|---|---|
| Stocks | 83.2% | 99.6% |
| Repurchase agreements | 0.9% | — |
| Cash & short-term funds | — | 0.4% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | RYHIX | PINK |
|---|---|---|
| US | 73.0% | 81.0% |
| DK | 1.4% | 6.8% |
| VG | — | 5.8% |
| IE | 3.3% | 4.7% |
| CH | 2.3% | — |
| GB | 1.8% | 1.8% |
| NL | 0.7% | — |
| IL | 0.6% | — |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do RYHIX and PINK overlap?
What stocks do RYHIX and PINK have in common?
Should I own both RYHIX and PINK?
Which holds more stocks, RYHIX or PINK?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.